Literature DB >> 33640673

Antimicrobial drugs bearing guanidine moieties: A review.

Seong-Heun Kim1, Dorothy Semenya1, Daniele Castagnolo2.   

Abstract

Compounds incorporating guanidine moieties constitute a versatile class of biologically interesting molecules with a wide array of applications. As such, guanidines have been exploited as privileged structural motifs in designing novel drugs for the treatment of various infectious and non-infectious diseases. In designing anti-infective agents, this moiety carries great appeal by virtue of attributes such as hydrogen-bonding capability and protonatability at physiological pH in the context of interaction with biological targets. This review provides an overview of recent advances in hit-to-lead development studies of antimicrobial guanidine-containing compounds with the aim to highlight their structural diversity and the pharmacological relevance of the moiety to drug activity, insofar as possible. In so doing, emphasis is put on chemical and microbiological properties of such compounds in relation to antibacterial, antifungal and antimalarial activities.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antimicrobials; Bacteria; Fungal infections; Guanidine; Malaria; Tuberculosis

Mesh:

Substances:

Year:  2021        PMID: 33640673     DOI: 10.1016/j.ejmech.2021.113293

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

Review 1.  A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.

Authors:  Wenjing Liu; Min He; Yongjun Li; Zhiyun Peng; Guangcheng Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

2.  Development of Dicationic Bisguanidine-Arylfuran Derivatives as Potent Agents against Gram-Negative Bacteria.

Authors:  Catarina Bourgard; Diego Rodríguez-Hernández; Anastasia Rudenko; Carolin Rutgersson; Martin Palm; D G Joakim Larsson; Anne Farewell; Morten Grøtli; Per Sunnerhagen
Journal:  Antibiotics (Basel)       Date:  2022-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.